Haoxi Health Technology LTD F-1 registration statements

Haoxi Health Technology plans a unit offering to raise capital while navigating complex PRC regulatory requirements.

Haoxi Health Technology Limited plans to raise capital through a unit offering, each unit containing a Class A Ordinary Share (or pre-funded warrant) and warrants, to fund working capital, acquisitions, and compliance improvements.

Haoxi Health Technology plans to raise capital through a unit offering, each consisting of Class A Ordinary Shares and warrants.

Haoxi Health Technology plans to offer units consisting of Class A Ordinary Shares and warrants to raise capital.

Haoxi Health Technology plans to offer units consisting of Class A Ordinary Shares and warrants to raise capital for working capital, acquisitions, and compliance improvements.

Haoxi Health Technology plans to raise capital through a unit offering consisting of Class A Ordinary Shares and warrants, aiming for approximately $14.4 million if the over-allotment option is fully exercised.

Haoxi Health Technology Limited details the terms of its Series A and B Warrants in a recent SEC filing, outlining exercise conditions, price adjustments, and potential fundamental transaction scenarios.

Haoxi Health Technology Limited plans to offer 1,773,049 units, each including a Class A Ordinary Share (or pre-funded warrant), a Series A warrant, and a Series B warrant, to enhance working capital and for general corporate purposes.

Haoxi Health Technology launches a unit offering, comprising Class A ordinary shares and warrants, aiming to raise $11.5 million for working capital and strategic investments.

Haoxi Health Technology Limited files an amendment to its Form F-1 registration statement to include updated consents from its auditor and revised memorandum and articles of association.